Vertebroplasty for pain relief and spinal stabilization in multiple myeloma

Flavio Tancioni, Martin Lorenzetti, Pierina Navarria, Andrea Nozza, Luca Castagna, Paolo Gaetani, Enrico Aimar, Daniel Levi, Antonio Di Ieva, Patrizia Pisano, Armando Santoro, Marta Scorsetti, Riccardo Rodriguez Y Baena

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Mechanical stabilization of oncological vertebral fractures with cement augmentation is the first mechanism of pain relief, with or without restoration of vertebral body height. The aim of this study was to assess the safety and efficacy of vertebroplasty for painful vertebral body fractures in patients with multiple myeloma, in each phase of the disease. The authors reviewed a consecutive group of patients with multiple myeloma who underwent vertebroplasty at our Institute between November 2003 and December 2005. Twenty-eight levels were performed on 11 patients during 14 treatment sessions. All patients suffered from intractable back pain, and presented various lesion types (with and without fractures of posterior wall, and with and without epidural disease). The preoperative median visual analog scale (VAS) score was 7. The median duration of symptoms was 1.1 months. Eight patients were ambulating with orthopaedic devices (57%) in the pre-treatment period. Improvement or complete pain relief was observed in all patients (immediately in 8 cases, and after 2 days in 6 cases). The median VAS pain score decreased to 2. There was no symptomatic procedure-related complication. There were three cases (21%) of PMMA leakage: in the disc space in one case (7%), and in the anterior spinal canal in two cases (14%). Complete removal of orthopaedic devices was obtained in five patients (36%). No new deformation or collapse of the treated vertebrae was observed during the follow-up (range 1 day-25 months). In conclusion, vertebroplasty is a safe and efficient procedure in the treatment of painful vertebral body fractures in patients with multiple myeloma, without potential contraindications, such as fractures of the posterior wall or epidural disease. We also treated three and more levels in 28% of cases in a single session without complications. Due to the early pain relief and the low complication rate, it is possible to expand the indication to vertebroplasty for the prophylactic augmentation of those vertebral bodies at risk of fracture in which significant neoplastic substitution of the body is present.

Original languageEnglish
Pages (from-to)151-157
Number of pages7
JournalNeurological Sciences
Volume31
Issue number2
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Vertebroplasty
Multiple Myeloma
Pain
Orthopedics
Device Removal
Intractable Pain
Spinal Canal
Body Height
Polymethyl Methacrylate
Pain Measurement
Back Pain
Visual Analog Scale
Spine
Therapeutics
Safety
Equipment and Supplies

Keywords

  • Bone cement
  • Myeloma
  • Spine
  • Vertebral fracture
  • Vertebroplasty

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

Vertebroplasty for pain relief and spinal stabilization in multiple myeloma. / Tancioni, Flavio; Lorenzetti, Martin; Navarria, Pierina; Nozza, Andrea; Castagna, Luca; Gaetani, Paolo; Aimar, Enrico; Levi, Daniel; Di Ieva, Antonio; Pisano, Patrizia; Santoro, Armando; Scorsetti, Marta; Y Baena, Riccardo Rodriguez.

In: Neurological Sciences, Vol. 31, No. 2, 04.2010, p. 151-157.

Research output: Contribution to journalArticle

Tancioni, Flavio ; Lorenzetti, Martin ; Navarria, Pierina ; Nozza, Andrea ; Castagna, Luca ; Gaetani, Paolo ; Aimar, Enrico ; Levi, Daniel ; Di Ieva, Antonio ; Pisano, Patrizia ; Santoro, Armando ; Scorsetti, Marta ; Y Baena, Riccardo Rodriguez. / Vertebroplasty for pain relief and spinal stabilization in multiple myeloma. In: Neurological Sciences. 2010 ; Vol. 31, No. 2. pp. 151-157.
@article{e6d57d8010994413917e6f9a6eaff6e5,
title = "Vertebroplasty for pain relief and spinal stabilization in multiple myeloma",
abstract = "Mechanical stabilization of oncological vertebral fractures with cement augmentation is the first mechanism of pain relief, with or without restoration of vertebral body height. The aim of this study was to assess the safety and efficacy of vertebroplasty for painful vertebral body fractures in patients with multiple myeloma, in each phase of the disease. The authors reviewed a consecutive group of patients with multiple myeloma who underwent vertebroplasty at our Institute between November 2003 and December 2005. Twenty-eight levels were performed on 11 patients during 14 treatment sessions. All patients suffered from intractable back pain, and presented various lesion types (with and without fractures of posterior wall, and with and without epidural disease). The preoperative median visual analog scale (VAS) score was 7. The median duration of symptoms was 1.1 months. Eight patients were ambulating with orthopaedic devices (57{\%}) in the pre-treatment period. Improvement or complete pain relief was observed in all patients (immediately in 8 cases, and after 2 days in 6 cases). The median VAS pain score decreased to 2. There was no symptomatic procedure-related complication. There were three cases (21{\%}) of PMMA leakage: in the disc space in one case (7{\%}), and in the anterior spinal canal in two cases (14{\%}). Complete removal of orthopaedic devices was obtained in five patients (36{\%}). No new deformation or collapse of the treated vertebrae was observed during the follow-up (range 1 day-25 months). In conclusion, vertebroplasty is a safe and efficient procedure in the treatment of painful vertebral body fractures in patients with multiple myeloma, without potential contraindications, such as fractures of the posterior wall or epidural disease. We also treated three and more levels in 28{\%} of cases in a single session without complications. Due to the early pain relief and the low complication rate, it is possible to expand the indication to vertebroplasty for the prophylactic augmentation of those vertebral bodies at risk of fracture in which significant neoplastic substitution of the body is present.",
keywords = "Bone cement, Myeloma, Spine, Vertebral fracture, Vertebroplasty",
author = "Flavio Tancioni and Martin Lorenzetti and Pierina Navarria and Andrea Nozza and Luca Castagna and Paolo Gaetani and Enrico Aimar and Daniel Levi and {Di Ieva}, Antonio and Patrizia Pisano and Armando Santoro and Marta Scorsetti and {Y Baena}, {Riccardo Rodriguez}",
year = "2010",
month = "4",
doi = "10.1007/s10072-009-0197-5",
language = "English",
volume = "31",
pages = "151--157",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "2",

}

TY - JOUR

T1 - Vertebroplasty for pain relief and spinal stabilization in multiple myeloma

AU - Tancioni, Flavio

AU - Lorenzetti, Martin

AU - Navarria, Pierina

AU - Nozza, Andrea

AU - Castagna, Luca

AU - Gaetani, Paolo

AU - Aimar, Enrico

AU - Levi, Daniel

AU - Di Ieva, Antonio

AU - Pisano, Patrizia

AU - Santoro, Armando

AU - Scorsetti, Marta

AU - Y Baena, Riccardo Rodriguez

PY - 2010/4

Y1 - 2010/4

N2 - Mechanical stabilization of oncological vertebral fractures with cement augmentation is the first mechanism of pain relief, with or without restoration of vertebral body height. The aim of this study was to assess the safety and efficacy of vertebroplasty for painful vertebral body fractures in patients with multiple myeloma, in each phase of the disease. The authors reviewed a consecutive group of patients with multiple myeloma who underwent vertebroplasty at our Institute between November 2003 and December 2005. Twenty-eight levels were performed on 11 patients during 14 treatment sessions. All patients suffered from intractable back pain, and presented various lesion types (with and without fractures of posterior wall, and with and without epidural disease). The preoperative median visual analog scale (VAS) score was 7. The median duration of symptoms was 1.1 months. Eight patients were ambulating with orthopaedic devices (57%) in the pre-treatment period. Improvement or complete pain relief was observed in all patients (immediately in 8 cases, and after 2 days in 6 cases). The median VAS pain score decreased to 2. There was no symptomatic procedure-related complication. There were three cases (21%) of PMMA leakage: in the disc space in one case (7%), and in the anterior spinal canal in two cases (14%). Complete removal of orthopaedic devices was obtained in five patients (36%). No new deformation or collapse of the treated vertebrae was observed during the follow-up (range 1 day-25 months). In conclusion, vertebroplasty is a safe and efficient procedure in the treatment of painful vertebral body fractures in patients with multiple myeloma, without potential contraindications, such as fractures of the posterior wall or epidural disease. We also treated three and more levels in 28% of cases in a single session without complications. Due to the early pain relief and the low complication rate, it is possible to expand the indication to vertebroplasty for the prophylactic augmentation of those vertebral bodies at risk of fracture in which significant neoplastic substitution of the body is present.

AB - Mechanical stabilization of oncological vertebral fractures with cement augmentation is the first mechanism of pain relief, with or without restoration of vertebral body height. The aim of this study was to assess the safety and efficacy of vertebroplasty for painful vertebral body fractures in patients with multiple myeloma, in each phase of the disease. The authors reviewed a consecutive group of patients with multiple myeloma who underwent vertebroplasty at our Institute between November 2003 and December 2005. Twenty-eight levels were performed on 11 patients during 14 treatment sessions. All patients suffered from intractable back pain, and presented various lesion types (with and without fractures of posterior wall, and with and without epidural disease). The preoperative median visual analog scale (VAS) score was 7. The median duration of symptoms was 1.1 months. Eight patients were ambulating with orthopaedic devices (57%) in the pre-treatment period. Improvement or complete pain relief was observed in all patients (immediately in 8 cases, and after 2 days in 6 cases). The median VAS pain score decreased to 2. There was no symptomatic procedure-related complication. There were three cases (21%) of PMMA leakage: in the disc space in one case (7%), and in the anterior spinal canal in two cases (14%). Complete removal of orthopaedic devices was obtained in five patients (36%). No new deformation or collapse of the treated vertebrae was observed during the follow-up (range 1 day-25 months). In conclusion, vertebroplasty is a safe and efficient procedure in the treatment of painful vertebral body fractures in patients with multiple myeloma, without potential contraindications, such as fractures of the posterior wall or epidural disease. We also treated three and more levels in 28% of cases in a single session without complications. Due to the early pain relief and the low complication rate, it is possible to expand the indication to vertebroplasty for the prophylactic augmentation of those vertebral bodies at risk of fracture in which significant neoplastic substitution of the body is present.

KW - Bone cement

KW - Myeloma

KW - Spine

KW - Vertebral fracture

KW - Vertebroplasty

UR - http://www.scopus.com/inward/record.url?scp=77953537744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953537744&partnerID=8YFLogxK

U2 - 10.1007/s10072-009-0197-5

DO - 10.1007/s10072-009-0197-5

M3 - Article

C2 - 20076982

AN - SCOPUS:77953537744

VL - 31

SP - 151

EP - 157

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 2

ER -